Shenzhen Salubris Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 15.65% vs -2.64% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.29% vs 2.42% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,228.40",
          "val2": "1,062.20",
          "chgp": "15.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "238.50",
          "val2": "308.50",
          "chgp": "-22.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.20",
          "val2": "4.30",
          "chgp": "-2.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.40",
          "val2": "2.80",
          "chgp": "21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "225.80",
          "val2": "202.90",
          "chgp": "11.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "194.10%",
          "val2": "188.20%",
          "chgp": "0.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.33% vs 19.18% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.87% vs 4.20% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,306.70",
          "val2": "3,975.50",
          "chgp": "8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,065.00",
          "val2": "1,080.40",
          "chgp": "-1.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.00",
          "val2": "17.70",
          "chgp": "24.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-114.40",
          "val2": "-143.00",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "652.80",
          "val2": "605.20",
          "chgp": "7.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "145.90%",
          "val2": "168.90%",
          "chgp": "-2.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,228.40

1,062.20

15.65%

Operating Profit (PBDIT) excl Other Income

238.50

308.50

-22.69%

Interest

4.20

4.30

-2.33%

Exceptional Items

3.40

2.80

21.43%

Consolidate Net Profit

225.80

202.90

11.29%

Operating Profit Margin (Excl OI)

194.10%

188.20%

0.59%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 15.65% vs -2.64% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 11.29% vs 2.42% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,306.70

3,975.50

8.33%

Operating Profit (PBDIT) excl Other Income

1,065.00

1,080.40

-1.43%

Interest

22.00

17.70

24.29%

Exceptional Items

-114.40

-143.00

20.00%

Consolidate Net Profit

652.80

605.20

7.87%

Operating Profit Margin (Excl OI)

145.90%

168.90%

-2.30%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 8.33% vs 19.18% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 7.87% vs 4.20% in Dec 2024

All Annual Results